ABSTRACT
Introduction
Neural tube defects (NTD) are a group of birth defects caused by a failure of neural tube closure. The underlying gene-environment interaction is influenced by several factors including geography, ethnicity and time (1) . The prevalence of NTDs (1993) (1994) in Turkey was found to be around 3 out of every 1000 births (2) . This was increased significantly to 4.39 per 1000 births in the eastern Black Sea region after the Chernobyl nuclear power station accident (3) . Elevated maternal serum alpha-fetoprotein levels and ultrasound scan (US) are the most important diagnostic aids in fetal NTD screening.
Periconceptional daily 400 microgram intake of folic acid (FA) lessened the rates of NTD to 0.6-1 per 1000 births (4) . But another low risk population study could not show this relationship between MS folate, vitamin B12 (vit B12) during pregnancy (5) . The role of serum zinc (Zn) levels during pregnancy is indispensable in the pathogenesis of NTDs (6) . Maternal obesity, hyperinsulinemia is also found as strong risk factors for NTDs (7, 8) . The results in the relationship between 5,10-methylenetetrahydrofolate reductase (MTHFR) c.677 C>T (rs1801133) single-nucleotide polymorphism (SNP) and NTD may remain controversial (9) .
This study aimed to describe NTDs by using ultrasonography and fetal magnetic resonance imaging (MRI) and to analyze various maternal risk factors including demographics, body mass index (BMI), prenatal FA intake and bioassays of FA, vit B12, Zn and MTHFR c.677C > T (rs1801133) SNP. 
Materials and Method

Participants
This prospective cohort study of 48 fetuses with NTDs was conducted at a single tertiary medical center in the Thrace region of Turkey (2013 Turkey ( -2015 . The research was approved by the Institutional Ethics Committee (2013/27). The data obtained from 20 gestationally matched healthy pregnancies was used as controls for some demographics and serum analyses. Informed consent has been obtained from all pregnant women included in the study.
Data collection and Measurements
All the features of 48 fetuses with NTDs diagnosed by ultrasonography (Voluson 730 Pro, GE, Austria) were analyzed. Anterior curving of the cerebellar hemispheres with obliterated cisterna magna was defined as banana sign, frontal bossing of the cranium was known as lemon sign, both the cerebellum and brain stem extend into the foramen magnum was described as Chiari II. Fetal MRI (1.5T, GE, Virginia, USA) was employed for further evaluation of 6 NTDs ( Figure 1 ).
Direct pregnancy interviews included questions about age, gravidity, parity, place of birth, height, weight, nutrition, periconceptional FA, Zn and vit B12 intake and family history.
Serum samples were obtained from each mother when the diagnosis of fetal NTD was confirmed and kept at -80oC until assayed and analyzed for vit B12 and FA (Advia Centaur XP and Siemens) and Zn (Atomic Absorption Spectrophotometer, Shimadzu AA 6800). Maternal serum samples were also collected from 20 gestational age matched uncomplicated pregnancies, which constituted the control group.
Methylenetetrahydrofolate reductase c.677C>T (rs 1801133) single-nucleotide polymorphism was investigated in 20 mothers who had fetuses with NTDs and also had occlusive vascular complications in their family histories. Peripheral blood samples were drawn into 2 cc EDTA tubes and DNA isolation was performed using Qiagen DNA isolation kits (EZ1® DNA Blood 200 μL Kit; Qiagen, Hilden, North Rhine-Westphalia, Germany) with an EZ1 Advanced XL (Qiagen) nucleic acid isolation system. DNA concentration and the purity of isolated DNA samples were measured using a NanoDrop device (NanoDrop 2000C; Thermo Fisher Scientific Inc., Wilmington, MA, USA). After measuring the concentration and purity, an amplification polymerase chain reaction (PCR) for pyro-sequencing was performed according to the manufacturer's recommended PCR protocol. A PyroMark PCR kit (Qiagen, Hilden, North Rhine-Westphalia, Germany) and primers in a PyroMark Custom Assay Kit (Qiagen) were used for detection of MTHFR c.677C > T SNP. The amplification PCR was performed with initial denaturation at 95°C for 15 min. followed by 45 cycles at 94°C for 30 seconds, 60°C for 30 seconds and 72°C for 30 seconds, then a final extension at 72°C for 10 min. After the PCR amplification, sequencing primers from a PyroMark Custom Assay Kit were used to pyro-sequence the PCR products and detect each polymorphism according to the manufacturer's instructions (PyroMark Q24 System; Qiagen, Hilden, North RhineWestphalia, Germany). The results were then analyzed using the PyroMark Q24 software system (Qiagen, Hilden, North Rhine-Westphalia, Germany), and the genotypes for polymorphisms were determined using samples from the NTD group (Qiagen, Hilden, North Rhine-Westphalia, Germany).
Conventional karyotyping (n=12) was performed in the NTDs with additional anomalies. The results were evaluated by an IBM® SPSS® (Statistical Package for the Social Sciences, California, USA). For comparison of means, a Student's T-Test was used for the parametric values. The statistical significance was defined as p<0.05.
Results
Population characteristics
The age (26.3±5.5 vs. 29±6.1) and gravidity (2.1±1.7 vs. 1.8±1.1) of mothers of NTD group and controls were comparable (p>0.05). Maternal BMIs of NTD group (24.3±3.2) were significantly higher than controls' (22±2.6), but FA intake was lower in the NTD group (8%) compared to the controls (40%) (p<0.05). There was no significant difference in serum FA, vit B12 or Zn levels between the women who had fetuses with NTDs and the controls (FA:12.6±6 vs. 15 
Ultrasonographic features of NTDs
Neural tube defects were countable as cranial (n=23; 47.9%) and spinal (n=25; 52.1%) which were referred at 12-21 gestational weeks (GW) with one exception, 37 weeks. The cranial defects included: acrania (n=3; 13%), iniencephaly (n=2; 8.6%), anencephaly (n=6; 26%), encephalocele (n=10; 43.4%) and exencephaly (n=2; 8.6%). The spinal defects were at the thoracolumbar (n=6; 24%), lumbar (n=9; 36%), lumbosacral (n=10; 40%) levels and 10.4% (n=5) of these cases had both cranial and spinal defects. These 5 cases were grouped in cranial defects. Prenatal ultrasonographic signs of the NTDs were ventriculomegaly (n=17; 68%), ''lemon'' (n=17; 68%) and ''banana'' signs (n=14; 56%). Ten (40%) had all three signs and 22 (88%) had at least one of these findings. Chiari II malformation was diagnosed in eight of the cases (32%).
Fetal MRI was performed in 6 cases of the NTDs (Figure 1) , however, no additional benefit could be obtained to the ultrasonography (10).
NTD-associated anomalies
According to prenatal and postnatal evaluations, 12 out of 48 fetuses with NTDs (25%) had additional anomalies. These additional anomalies were cystic hygroma, low-set ears, micrognathia, heart anomalies, renal anomalies, diaphragmatic hernias, and genital and limb anomalies. Fetal conventional karyotyping was performed for these cases and revealed that two fetuses had Trisomy 21 whereas the others had normal karyotypes. One with Trisomy 21 exhibited low-set ears with a posterior encephalocele. The other Trisomy 21 showed lumbar spina bifida, low-set ears, ventricular septal defect and diaphragmatic hernia.
MTHFR c.677C > T SNP in NTD group
When we evaluated MTHFR c.677C > T SNPs of twenty NTD mothers associated with occlusive vascular histories, we found no variation in two mothers (10%) and homozygosity in three mothers (15%), but heterozygosity in 15 mothers (75%). 
Discussion
The prevalence of NTDs was 11.4 per 10000 births (48/42000) in Northwestern Turkey. Lumbosacral spinal bifida (SB) and encephalocele were the most common forms. The obesity and low FA intake have a role in the occurrence of NTDs. However, serum levels of FA, vit B12, Zn of NTDaffected mothers were not different in comparison to normal. The prevalence rate of homozygous MTHFR c.677C > T SNP was 15% among NTD mothers. In terms of ultrasonographic signs of fetal NTDs, the most common signs were lemon sign (68%) and ventriculomegaly (68%). Chiari type II malformation was observed 32% of the NTDs. One of the four NTDs (25%) had an additional anomaly.
The incidence of NTDs in the northwestern part was lower than those in other parts (0. 3%) of Turkey. These numbers range from 0.46% to 0.27% in different countries (11) (12) (13) . The importance of the environmental factors on the occurrence of NTD was confirmed. The rates of NTD (4.39 per 1000 births) and anencephaly (2.46 per 1000 births) after the Chernobyl accident was increased (3). Although no significant relationship with maternal age or gravidity was supported in our study but the role of obesity on the occurrence of NTDs was found to be unavoidable (7, 8, 13) . Higher dose prenatal FA intake for the women with diabetes, obesity, malabsorption and those using antiepileptic drugs is inevitable (14) . Nevertheless, not all cases of NTD are preventable by increasing the folate intake (15) .
Although several studies reported low maternal serum FA, vit B12 and Zn levels among NTD-affected pregnancies, our results which come from a low NTD-rate area were in line with the studies which showed a lack of this correlation.
The epidemiological study in a low rate area reported no association between maternal serum folate (4.13-4.28 ng/ml), vit B12 (482.8-520.3 pg/ml) and the NTD risk (5). Our study also found that the levels of folate levels and vit B12 were around (12.6-15.6 ng/ml) and (222.6-232 pg/ml), respectively. Although regional vit B12 levels were low, serum folate levels in our study were higher than those in literature. That may cause a low rate in NTDs with in our area. However, according to another study, the mean of maternal serum zinc levels in the NTDs (835.6 +/-333.8 μg/L) was significantly lower than the controls' (1035.7 +/-299.8 μg /L) (6) . Serum zinc levels were found to be (153.2±77.2) versus (159mg/dl±45.7) with no significance in our study.
The relationship between MTHFR c.677C > T SNP and NTD is not clear. The prevalence of homozygous MTHFR c.677C > T SNP among NTD affected mothers was 15% in our study. The 677T-C mutation might not be responsible for a large percentage of folic-acid preventable NTD cases (16) . Another study suggested that vit B12 fortification might reduce NTDs more than FA fortification alone (17) . Consuming a folic acid supplement was affected by less acculturation in which less likely reporting consumption of supplements (18) . In studies conducted before the initiation of food fortification, folic acid supplementation provided protection against NTDs. This strong FA protection effect against NTD might also depend on the initial NTD rate (15) . Some newer post fortification studies could not demonstrate this relationship (19) .
The study of Nicolaides et al showed that the lemon sign in the 54 of 70 fetuses (77%) with open SB at 16-23 GW and the banana sign was met in 12/21 (57%) fetuses (20) . In addition, the cerebellum could not be displayed in 8 (11%) cases ultrasonographically. Another study found that 98% of open SB fetuses show the lemon sign until 24 GW, 95% of open SB fetuses with cerebellar abnormalities irrespective of gestational age (21) .
On the basis of these data, a new approach is proposed for the investigation of patients at high risk for fetal open SB that is computer aided detection of SB. The curvature scale space features of fetal skulls, such as lemon sign, extracted from ultrasound images were studied firstly (22) .
Fetal MRI may be useful for SB fetuses in the evaluation of fetal outcome in terms of ambulation, bladder functions, scoliosis or dysphagia (23) . In this study, fetal MRI, which was an effective, noninvasive means of assessing fetal CNS anatomy, was performed in only 6 fetal NTDs to analyze the abnormalities in corpus callosum and posterior fossa anatomy (24) .
According to prenatal and postnatal evaluations, 12 out of 48 fetuses with NTDs (25%) had additional anomalies in our study. On the other hand, the rate of additional anomalies among NTDs was reported to be 32% in an observational study from the southern part of Turkey (25) .
Strengths and limitations
The strength of this prospective cohort study is to analyze fetal NTD profile at a local region in Turkey. As a limitation of this small sized study, the number of controls could be increased to gain more statistical power in bioassays of FA, vit B12 and Zn under the light of local dietary data.
Conclusion
The northwestern region appeared to be a relatively low prevalence area of Turkey for fetal neural tube defects. Any association with maternal serum folic acid, vit B12 and zinc levels could not be shown in this region. 
